Accordingly, a recent cancer genome sequencing study on MLL-r AML patients has identified mutations in SPI1gene [100], a powerful HSPC transcription factor whose role in murine AML had already been defined at genomic scale [101]. The gene discussed is KMT2A; the disease is cancer.